PERTinent Updates
Issue 32

Sponsored by |
|
![]() |
|
![]() |
|
Issue 32 |
|
Welcome to issue 32 of PERTinent Updates, featuring a select group of articles for your review. We aim to inform and update our members with the most recent major developments in the fields of PE/VTE so that we in the PERT Consortium® can continue to be at the leading edge of improving care for this vulnerable and overlooked group of patients. See our recent Position Paper in CHEST on how to diagnose and treat patient with PE during COVID-19. |
|
![]() |
|
Position Paper |
|
Diagnosis and Treatment of Pulmonary Embolism During the COVID-19 Pandemic: A Position Paper from the National PERT Consortium. |
|
PE Epidemiology |
|
Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018. |
|
PE Treatment – ECMO |
|
Mid-term outcomes with the use of extracorporeal membrane oxygenation for cardiopulmonary failure secondary to massive pulmonary embolism. |
|
PE Treatment – Surgical Management |
|
Survival and Right Ventricular Function After Surgical Management of Acute Pulmonary Embolism |
|
PE Treatment – Percutaneous Thrombectomy |
|
Percutaneous thrombectomy in patients with massive and very high-risk submassive acute pulmonary embolism. |
|
PE – Outpatient Management |
|
British Thoracic Society Quality Standards for outpatient management of pulmonary embolism. |
|
PERT Consortium – From Our Own |
|
How I Do It: The PERT Concept: A Step-by-Step Approach to Managing PE |
|
Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19). |
|
One-Year Echocardiographic, Functional, and Quality of Life Outcomes After Ultrasound-Facilitated Catheter-Based Fibrinolysis for Pulmonary Embolism. |
|
|